Emerging Biomarkers for Early Detection and Prognosis of Liver Diseases

Traditional biomarkers are essential for liver assessment, while new ones like microRNAs, exosomes, MMPs, and TIMPs improve early diagnosis and monitoring. They support personalized care but need further validation for routine use.

Authors

Institutions

Publication Details

Journal
Current Pharmaceutical Design
Published
2025-10-18
DOI
https://doi.org/10.2174/0113816128384721250924030943
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Emerging Biomarkers for Early Detection and Prognosis of Liver Diseases

Jyoti Yadav, Saumya Das
Current Pharmaceutical Design
Liver Disease Diagnosis and Treatment
article

Emerging Biomarkers for Early Detection and Prognosis of Liver Diseases

Jyoti Yadav, Saumya Das
article en

Abstract

Traditional biomarkers are essential for liver assessment, while new ones like microRNAs, exosomes, MMPs, and TIMPs improve early diagnosis and monitoring. They support personalized care but need further validation for routine use.

Current Pharmaceutical DesignVol. 32(18)
Jaypee Institute of Information Technology (IN), Sharda University (IN)
Openalex Percentile: Top 60%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Emerging Biomarkers for Early Detection and Prognosis of Liver Diseases — Jyoti Yadav, Saumya Das · Current Pharmaceutical Design (2025) | TGRS Research Map | TGRS